右美托咪定对老年高血压患者全麻诱导气管插管应激反应的影响被引量：64

Influence of dexmedetomidine on intubation stress reactions under general anesthesia induction in senile hypertension patients

在线阅读下载PDF

导出

摘要目的比较不同剂量右美托咪定对老年高血压患者全麻诱导期间气管插管引起的血流动力学反应的影响。方法将60~75岁、ASAⅠ~Ⅱ级行全麻手术的原发性高血压患者60例,分为3组,D1、D2组和对照组（C组）,每组20例。D1、D2组于麻醉诱导前15min,采用微量泵将4μg/mL的右美托咪定分别以0.2、0.6μg/kg剂量静脉泵入,在10min内完成;C组以同样方法泵入0.9%氯化钠溶液。分别记录3组患者在试验用药前（T0）、诱导前（T1）、气管插管前（T2）、插管后1 min（T3）、5min（T4）的平均动脉压（MAP）、心率（HR）、血氧饱和度（SpO2）值。同时检测血浆去甲肾上腺素（NE）和肾上腺素（E）值。结果与用药前相比,D2组MAP在诱导前明显降低（P〈0.05）,C组和D1组则无明显变化（P〉0.05）;D2组HR在插管后1min明显减慢（P〈0.05）,而C和D1组HR在插管后1min显著增快（P〈0.05）。与C组相比,D2组在诱导前、插管前、插管后1min、插管后5min MAP和HR均明显降低（P〈0.05）,SpO2仅在诱导前有所下降（P〈0.05）;D1组各个时点的MAP、HR、SpO2与C组相比均无明显差异（P〉0.05）。与T0相比,T1时D2组血浆NE和E值降低（P〈0.01）;T3时C、D1组血浆NE和E值升高,D2组则降低（P〈0.01）。与C组相比,T1和T3时D2组血浆NE和E值均降低（P〈0.01）。结论静脉注射右美托咪定可安全抑制老年高血压患者全麻诱导时气管插管引起的血流动力学变化,维持老年高血压患者全麻诱导及气管插管期间循环功能稳定。并且0.6μg/kg的右美托咪定比0.2μg/kg能更加有效抑制气管插管引起的应激反应。 Objective To compare the influence of different doses of dexmedetomidine on the haemodynamic response caused by tracheal intubation during general anesthesia induction in senile hypertension patients.Methods Sixty patients with essential hypertension（EH）undergoing general anesthesia operation,60-75 years old,ASAⅠorⅡ,were randomly divided into the group D1,D2 and control group（C）,20 cases in each group.4μg/mL dexmedetomidine in the group D1 and D2was intravenously pumped at15 min before anesthesia induction with the doses of 0.2,0.6μg/kg respectively and completed within 10min;while the group C was pumped with sodium chloride injection by the same method.Mean artery pressure（MAP）,heart rate（HR）and O2saturation（SpO2）were monitored at before medication（T0）,before induction（T1）,before intubation（T2）,at 1min（T3）,5min（T4）after tracheal intubation.Meanwhile plasma norepinephrine（NE）and epinephrine（E）values were detected.Results Compared with before medication,MAP before induction in the group D2 was significantly decreased（P〈0.05）,however which in the group D1 and C had no obvious change（P〉0.05）;HR at 1min after tracheal intubation in the group D2 was significantly decreased（P〈0.05）,while which in the group C and D1 was significantly increased（P〈0.05）.Compared with the group C,MAP and HR before induction and tracheal intubation,at 1,5min after tracheal intubation in the group D2 were significantly decreased（P〈0.05）,SpO2 was significantly decreased only before induction（P〈0.01）;MAP,HR and SpO2 at each time points in the group D1 had no significant differences compared with the group C（P〉0.05）.Compared with T0,the plasma levels of NE and E at T1 in the group D2 were decreased（P〈0.01）;the plasma levels of NE and E at T3 in the group C and D1 were increased,while which in the group D2 were decreased（P〈0.01）.The plasma levels of NE and E at T1 and T3in the group D2 were decreased compared with the group C（P〈0.01）.Conclusion Intravenous injection of dexmedetomidine can safely inhibit the tracheal intubation caused hemodynamic changes and keep the hemodynamic stabilization during general anaesthesia induction and tracheal intubation period in senile hypertension patients.Furthermore dexmedetomidine 0.6μg/kg can more effectively inhibit the tracheal intubation caused stress reactions than dexmedetomidine 0.2μg/kg.

作者郑永超黄燕姜虹

机构地区上海交通大学医学院附属第九人民医院麻醉科

出处《重庆医学》 CAS 北大核心 2016年第9期1220-1222,1227,共4页 Chongqing medicine

关键词高血压右美托咪定气管插管全身麻醉 hypertension dexmedetomidine tracheal intubation general anesthesia

分类号 R614.2 [医药卫生—麻醉学]

作者简介郑永超（1984-），硕士，住院医师，主要从事静脉麻醉药物的镇静、镇痛机制研究。通讯作者，E—mail：yongcha00110@163．com

引文网络
相关文献

参考文献12

1Schaffrath E, Kuhlen R,Tonner PH. Analgesia and seda- tion in intensive care medicine[J]. Anaesthesist, 2004,53 (11):1111.
2Phan H,Nahata MC. Clinical uses of dexmedetomidine in pediatric patients[J]. Pediatric Drugs, 2008,10(1) : 49-69.
3Penttila J, Helminen A, Anttila M, et al. Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects [J]. Can J Physiol Pharmacol, 2004,82 (5) .. 359-362.
4Szumita PM, Baroletti SA, Anger KE. Sedation and anal- gesia in the intensive care unit: evaluating the role of dexrmedetomidine[J]. Am J Respir Crit Care Med, 2007, 64(1) :37-44.
5Neukirchen M,Kienbaum P. Sympathetic nervous system evaluation and importance for clinical general anesthesia [J]. Anesthesiology, 2008,109(6) : 1113-1131.
6Dogru K,Arik T, Yildiz K, et al. The effectiveness of in- tramuscular Dexmedetomidine on hemodynamic responses during tracheal intubation and Anesthesia induction of hy- pertensive patients: a randomized, double-blind, placebo- controlled study[J]. Curr Ther Res Clin Exp, 2007,68 (5) :292-302.
7Gerlach AT,Dasta JF. Dexmedetomidine: an updated re- view[J]. Ann Pharmacother, 2007,41 (2) : 245-252.
8Kunisawa T,Nagashima M, Hanada S, et al. Awake intu- bation under sedation using target-controlled infusion of dexmedetomidine: five case reports[J]. J Anesth, 2010,24 (5) :789-792.
9Kunisawa T, Nagata O, Nagashima M, et al. Dexmedeto- midine suppresses the decrease in blood pressure during anesthetic induction and blunts the cardiovascular re- sponse to tracheal intubation[J]. J Clin Anesth, 2009,21 (3) :194-199.
10Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions[J]. Anesth Analg, 2000,90(3) .. 699-705.